Status:
WITHDRAWN
SARS-CoV-2 Safety Study for the Treatment of COVID-19
Lead Sponsor:
DHA Coffee Co., Ltd
Conditions:
SARS-CoV-2
Eligibility:
All Genders
1-130 years
Phase:
PHASE2
Brief Summary
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic (ADN) Molecules.
Detailed Description
SARS-CoV-2 produced strong pluripotent stem cells and brain cells to change and disappear defective cells in virus variants, Covid-19 disease. Pluripotent stem cells produced strong cells serve as a r...
Eligibility Criteria
Inclusion
- SARS-CoV-2
Exclusion
Key Trial Info
Start Date :
January 28 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06489860
Start Date
January 28 2025
End Date
February 4 2025
Last Update
September 4 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.